l-carnitine and heart disease Carnitine therapy for the treatment of metabolic syndrome cardiovascular disease: Evidence and controversies Effects of L-carnitine and its
Description
10.1186/s13046-020-01690-z 71 TantonH.SewastianikT.SeoH
doi: 10.1016/j.jtemb.2014.11.009 43 BelaidiAAGunnAPWongBXAytonSAppukuttanATRobertsBRet al
Ahirwar DK, Nasser MW, Ouseph MM, Elbaz M, Cuitio MC, Kladney RD, et al
This process, called first-pass metabolism or first-pass effect, can destroy 50-90% of the absorbed dose
Mol Genet Metab 91:228233
